Ovarian Neoplasms

Showing 1 - 25 of 220

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • (no location specified)
Sep 3, 2023

Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)

Not yet recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • +3 more
  • disitamab vedotin
  • (no location specified)
Aug 15, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Improved Diagnosis of Ovarian Cancer

Recruiting
  • Ovarian Neoplasms
  • +6 more
    • Aarhus, Denmark
      Department of Gynaecology and Obstetrics, Aarhus University Hosp
    May 1, 2023

    Ovarian Tumors, Sarcopenia Trial in Chambéry (Sarcopenia diagnostic test)

    Recruiting
    • Ovarian Neoplasms
    • Sarcopenia
    • Sarcopenia diagnostic test
    • Chambéry, Savoie, France
      Centre Hospitalier Metropole Savoie
    Apr 17, 2023

    Ovarian Tumors Trial (MRI)

    Not yet recruiting
    • Ovarian Neoplasms
    • MRI
    • (no location specified)
    Mar 3, 2023

    Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker

    Recruiting
    • Ovarian Neoplasms
    • +2 more
      • Aarhus, Denmark
        Department of Gynaecology and Obstetrics, Aarhus University Hosp
      Mar 9, 2023

      Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)

      Not yet recruiting
      • Ovarian Neoplasms
      • Ovarian Diseases
      • (no location specified)
      Feb 23, 2023

      Ovarian Tumors Trial in Nanjing (Niraparib)

      Completed
      • Ovarian Neoplasms
      • Nanjing, China
        Zhongda hospital
      Feb 17, 2023

      Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

      Recruiting
      • Carcinoma, Ovarian Epithelial
      • +8 more
      • AB-1015
      • Iowa City, Iowa
        U. of Iowa Health Care
      Jan 30, 2023

      Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

      Recruiting
      • Uterine Cervical Neoplasms
      • +10 more
      • Pembrolizumab/Vibostolimab Co-Formulation
      • +11 more
      • Anchorage, Alaska
      • +65 more
      Jan 27, 2023

      Ovarian Tumors, Endometrial Tumors, NSCLC Trial in United Kingdom, United States (SGN-ALPV)

      Recruiting
      • Ovarian Neoplasms
      • +5 more
      • Fresno, California
      • +10 more
      Jan 20, 2023

      Ovarian Tumors, Endometrial Tumors, Breast Tumors Trial in Puerto Rico, United States (PF-07260437, B7-H4 IHC)

      Recruiting
      • Ovarian Neoplasms
      • +2 more
      • Duarte, California
      • +13 more
      Jan 19, 2023

      Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

      Active, not recruiting
      • Ovarian Neoplasms
      • +2 more
      • KU-0059436 (AZD2281)(PARP inhibitor)
      • Brussels, Belgium
      • +4 more
      Dec 19, 2022

      Ovarian Tumors Trial in Canada, Spain, United States (Niraparib, TSR-042, Bevacizumab)

      Recruiting
      • Ovarian Neoplasms
      • Birmingham, Alabama
      • +24 more
      Dec 9, 2022

      Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)

      Active, not recruiting
      • Ovarian Neoplasms
      • Mobile, Alabama
      • +27 more
      Nov 23, 2022

      Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

      Recruiting
      • Pelvic Cancer
      • +8 more
      • Ultrasound guided tru-cut biopsy
      • Leuven, Belgium
      • +3 more
      Nov 3, 2022

      Ovarian Cysts, Ovarian Cancer, Ovarian Tumors Trial (Detailed symptomregistration)

      Recruiting
      • Ovarian Cysts
      • +3 more
      • Detailed symptomregistration
      • Copenhagen, Denmark
        Claus Kim Høgdall
      Oct 25, 2022

      The Canadian/US Integrative Oncology Study

      Active, not recruiting
      • Breast Neoplasms
      • +3 more
        • Scottsdale, Arizona
        • +11 more
        Oct 21, 2022

        Niraparib in Treatment of Adult Approved Indications in South

        Recruiting
        • Ovarian Neoplasms
          • Busan, Korea, Republic of
            Inje University Haeundae Paik Hospital
          Oct 19, 2022

          Gynecologic Cancer, Cancer Metastatic, Ovarian Tumors Trial in Qilu, Chongqing (AK112)

          Active, not recruiting
          • Gynecologic Cancer
          • +4 more
          • Qilu, Shandong, China
          • +1 more
          Oct 8, 2022

          Ovarian Tumors, Recurrent Ovarian Carcinoma, Relapsed Ovarian Cancer Trial in Beijing (AK112 low dose, AK112 medium dose, AK112

          Terminated
          • Ovarian Neoplasms
          • +3 more
          • AK112 low dose
          • +2 more
          • Beijing, Beijing, China
            Chinese Academy of Medical Sciences and Peking Union Medical Col
          Oct 8, 2022